SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)
$44.42 -1.13 (-2.4808%)
Analysed SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) News Sources
Does Q1 2026 Earnings Beat Reshape the Bull Case for Supernus Pharmaceuticals (SUPN)?
06-05-2026
yahoo.com
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
06-05-2026
yahoo.com
What to Know About This Fund’s Sale of a Pharma Stock Up 56% in a Year
12-05-2026
fool.com
5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call
15-05-2026
yahoo.com
3 Growth Stocks We Approach with Caution
19-05-2026
yahoo.com
3 Small-Cap Stocks That Concern Us
20-05-2026
yahoo.com
3 Stocks Under $50 with Open Questions
22-05-2026
yahoo.com
Supernus CVR Milestone Triggers Cash Outflow And Undervalued Stock Debate
24-05-2026
yahoo.com
Supernus Pharmaceuticals to Participate in June Investor Conferences
27-05-2026
yahoo.com
1 Cash-Heavy Stock on Our Watchlist and 2 Facing Challenges
05-06-2026
yahoo.com
What is the current price of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The current price of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is $44.42.
SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) since the previous trading day is $-1.13.
SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) since the previous trading day is -2.4808%.
What is the most recent average sentiment score for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The most recent average sentiment score for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The most recent sentiment for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is .
SEC-8K** Filing Available For SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.